[BREAKING] [Exclusive] Technology transfer to Novartis, a global pharmaceutical company of Medipick, will receive 100 billion won in down payment without obligation to return.

1 April Share

[BREAKING] [Exclusive] Technology transfer to Novartis, a global pharmaceutical company of Medipick, will receive 100 billion won in down payment without obligation to return.

メディピック、グローバル製薬会社ノバティスに技術移転、返還義務のない契約金1千億ウォンを受け取る予定。

[单独] 向medipic全球制药公司novartis转让技术，将领取没有返还义务的1千亿韩元定金

[Только] Компания Medic Global Pharmacy Novatis планирует получить 100 миллиардов вон за передачу технологии и без обязательства возвращения.

[단독] 메디픽 글로벌제약사 노바티스에 기술이전, 반환 의무없는 계약금 1천억원 수령 예정 [More News]